Incyte (INCY)
(Delayed Data from NSDQ)
$57.79 USD
+0.49 (0.86%)
Updated May 31, 2024 04:00 PM ET
After-Market: $57.80 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Incyte Corporation [INCY]
Reports for Purchase
Showing records 201 - 220 ( 248 total )
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Key Takeaways From Meeting With Management
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Previewing 4Q13 and 2014 Guidance
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Initiating with Buy Rating and $68 TP
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Initiating on US Biotechnology Sector
Provider: Nomura